New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
agilon health, inc.
AGL
Shape
US Flag

NYSE

Unprofitable

Unprofitable

1B

Medical - Care Facilities

Next Earning date - 07 Nov 2024

1B

Medical - Care Facilities

Next Earning date - 07 Nov 2024

3.22USD
Shape-0.10 ( -3.01%)
favorite-chart

Relative Strenght

4
favorite-chart

Volume Buzz

-31%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

84%

Quote Panel

Shape
Updated October 12, 2024
1W 2.22 % 1M -8.78 % 3M -50.76 % 1Y -82.26 %

Key Metrics

Shape
  • Market Cap

    1.32B


  • Shares Outstanding

    411.48M


  • Share in Float

    302.82M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    3.22


  • Average Volume

    4.39M


  • Beta

    0.54


  • Range

    2.995-20.37


  • Industry

    Medical - Care Facilities


  • Website

    https://agilonhealth.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.25x

P/S Ratio

2.02x

P/B Ratio

0.1

Debt/Equity

-4.5%

Net Margin

$-0.5

EPS

How AGL compares to sector?

P/E Ratio

Relative Strength

Shape

AGL

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$7B

Shape398%

2025-Revenue

$0.19

Shape-157%

2025-EPS

$603M

Shape-1548%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

BNP Paribas

initialise

Previous: Not converted

2023-10-20

Now: Neutral

Exane BNP Paribas

initialise

Previous: Not converted

2023-10-20

Now: Neutral

Benchmark

initialise

Previous: Not converted

2023-10-20

Now: Buy

UBS

initialise

Previous: Not converted

2023-10-20

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.07
vs -0.09

Q4.22

arrow
arrow

N/A

-0.14
vs -0.15

Q1.23

arrow
arrow

+2239%

0.04
vs 0

Q2.23

arrow
arrow

N/A

-0.04
vs -0.04

Q3.23

arrow
arrow

N/A

-0.06
vs -0.07

Q4.23

arrow
arrow

N/A

-0.41
vs -0.14

Q1.24

arrow
arrow

-75%

0.01
vs 0.04

Q2.24

arrow
arrow

N/A

-0.07
vs -0.04

Q3.24

arrow
arrow

N/A

-0.10
vs -0.06

Q4.24

arrow
arrow

N/A

-0.16
vs -0.41

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+52%

694.9M  vs 458.6M

Q4.22

arrow
arrow

+49%

689.8M  vs 462.9M

Q1.23

arrow
arrow

+74%

1.1B  vs 653.4M

Q2.23

arrow
arrow

+71%

1.1B  vs 670.1M

Q3.23

arrow
arrow

+75%

1.2B  vs 694.9M

Q4.23

arrow
arrow

+53%

1.1B  vs 689.8M

Q1.24

arrow
arrow

+41%

1.6B  vs 1.1B

Q2.24

arrow
arrow

+29%

1.5B  vs 1.1B

Q3.24

arrow
arrow

+21%

1.5B  vs 1.2B

Q4.24

arrow
arrow

+39%

1.5B  vs 1.1B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-3%

-0.03
vs -0.02

Q4.22

arrow
arrow

-5%

-0.05
vs -0.03

Q1.23

arrow
arrow

+1%

0.01
vs -0.05

Q2.23

arrow
arrow

-2%

-0.02
vs 0.01

Q3.23

arrow
arrow

-4%

-0.04
vs -0.02

Q4.23

arrow
arrow

-28%

-0.28
vs -0.04

Q1.24

arrow
arrow

+0%

0
vs -0.28

Q2.24

arrow
arrow

-5%

-0.05
vs 0

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

187

187
vs 160

17%

Q4.22

arrow
arrow

183

183
vs 187

-2%

Q1.23

arrow
arrow

221

221
vs 183

21%

Q2.23

arrow
arrow

209

209
vs 221

-5%

Q3.23

arrow
arrow

204

204
vs 209

-2%

Q4.23

arrow
arrow

221

221
vs 204

8%

Q1.24

arrow
arrow

223

223
vs 221

1%

Q2.24

arrow
arrow

228

228
vs 223

2%

Earnings Growth

Latest News